Kitajima M, Oka S, Yasuhi I, Fukuda M, Rii Y, Ishimaru T
Department of Obstetrics and Gynecology, Nagasaki University School of Medicine, Nagasaki, Japan.
Obstet Gynecol. 2001 May;97(5 Pt 1):776-80. doi: 10.1016/s0029-7844(01)01328-x.
To determine whether elevated midpregnancy maternal serum lipid levels predict newborn weight at term and the risk of large for gestational age (LGA) infants in women with positive diabetic screen but normal glucose tolerance test.
Japanese gravidas who had positive diabetic screens and normal 75-g oral glucose tolerance tests (GTT) at 24--32 weeks were enrolled. Subjects with complications, including diabetes, hypertension, or fetal anomalies were excluded, as were women with multifetal gestations. Fasting serum triglyceride, free fatty acids, and total cholesterol levels were measured at the time of GTT. We tested the association between maternal variables and birth weight by univariable analysis. We used multivariable analysis to test whether the association between fasting lipids and birth weight was independent of prepregnant maternal body mass index (BMI), maternal weight gain during pregnancy, and plasma glucose levels at GTT. We also used multiple logistic regression analysis to determine whether maternal hyperlipidemia, defined as more than the 75th percentile of each lipid, is a risk factor for having an LGA infant.
We enrolled 146 subjects. Among measured maternal lipids, only triglyceride levels correlated with birth weight in univariable analysis (r = 0.22, P =.009). Birth weight also was correlated with prepregnant maternal BMI (r = 0.18, P =.04) and fasting plasma glucose levels (r = 0.17, P =.04). The association between maternal fasting triglyceride level and birth weight remained significant after adjusting for prepregnant BMI, maternal weight gain, fasting plasma glucose levels, fetal gender, and gestational age at birth (P =.01). Logistic regression analysis showed that fasting maternal hypertriglyceridemia (over 259 mg/dL) was the significant predictor of LGA infants, independent of prepregnant BMI, maternal weight gain, and maternal plasma glucose levels (odds ratio 11.6; 95% confidence interval 1.1, 122; P =.04).
In women with positive diabetic screens but normal GTTs, fasting triglyceride levels at 24-32 weeks correlated positively with newborn weight at term, independent of maternal plasma glucose levels and obesity. Maternal fasting serum triglyceride levels in midpregnancy might be an independent predictor of fetal macrosomia in those women.
确定孕中期孕妇血清脂质水平升高是否能预测足月新生儿体重以及糖尿病筛查阳性但葡萄糖耐量试验正常的孕妇生出大于胎龄(LGA)儿的风险。
纳入24至32周糖尿病筛查阳性且75克口服葡萄糖耐量试验(GTT)正常的日本孕妇。排除患有包括糖尿病、高血压或胎儿畸形等并发症的受试者,以及多胎妊娠的妇女。在进行GTT时测量空腹血清甘油三酯、游离脂肪酸和总胆固醇水平。我们通过单变量分析检验孕妇变量与出生体重之间的关联。我们使用多变量分析来检验空腹血脂与出生体重之间的关联是否独立于孕前孕妇体重指数(BMI)、孕期体重增加以及GTT时的血糖水平。我们还使用多元逻辑回归分析来确定孕妇高脂血症(定义为每种脂质超过第75百分位数)是否是生出LGA儿的危险因素。
我们纳入了146名受试者。在测量的孕妇血脂中,单变量分析中只有甘油三酯水平与出生体重相关(r = 0.22,P = 0.009)。出生体重还与孕前孕妇BMI(r = 0.18,P = 0.04)和空腹血糖水平(r = 0.17,P = 0.04)相关。在调整孕前BMI、孕期体重增加、空腹血糖水平、胎儿性别和出生孕周后,孕妇空腹甘油三酯水平与出生体重之间的关联仍然显著(P = 0.01)。逻辑回归分析表明,空腹孕妇高甘油三酯血症(超过259毫克/分升)是LGA儿的显著预测因素,独立于孕前BMI、孕期体重增加和孕妇血糖水平(比值比11.6;95%置信区间1.1,122;P = 0.04)。
在糖尿病筛查阳性但GTT正常的孕妇中,24至32周的空腹甘油三酯水平与足月新生儿体重呈正相关,独立于孕妇血糖水平和肥胖情况。孕中期孕妇空腹血清甘油三酯水平可能是这些孕妇胎儿巨大儿的独立预测指标。